Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Chris Lange | Oct 1, 2018 at 11:50 AM EDT

Pfizer Announces Big Changes at the Top

Pfizer shares hit multiyear highs and nearly an all-time in Monday’s session after the pharma giant announced a succession plan…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 8, 2018 at 7:10 AM EDT

Major Biopharma Catalysts on September’s FDA Calendar

Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food…

Chris Lange | Aug 27, 2018 at 10:05 AM EDT

Pfizer Slips Despite Strong Late-Stage Results

Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 23, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Chris Lange | Aug 21, 2018 at 1:05 PM EDT

How the FDA Is Fighting the Nationwide EpiPen Shortage

The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school…

Paul Ausick | Aug 17, 2018 at 4:01 PM EDT

Apple, Caterpillar Dominate the Dow Friday

Caterpillar, Apple, Pfizer, and Cisco were Friday's top-gaining Dow stocks.

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Lee Jackson | Aug 15, 2018 at 10:00 AM EDT

Current Bull Market Not Over Until It’s Over: 5 US Stocks to Buy

Merrill Lynch now recommends these five outstanding dividend-paying U.S. stocks with solid upside potential.

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Aug 8, 2018 at 4:01 PM EDT

Disney, Pfizer Keep the Dow Flat Wednesday

The Dow is set to finish essentially flat Wednesday, with Disney and Caterpillar weighing on the index as Pfizer and…

Paul Ausick | Aug 6, 2018 at 4:01 PM EDT

Disney, DowDuPont Set Pace for the Dow Monday

Disney, DowDuPont, Pfizer, and Cisco Systems led the Dow higher Monday.

1 … 31 32 33 34 35 … 98

Pfizer : PFE

All Pfizer Articles

Pfizer Announces Big Changes at the Top

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Major Biopharma Catalysts on September’s FDA Calendar

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Apple, Caterpillar Dominate the Dow Friday

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Current Bull Market Not Over Until It’s Over: 5 US Stocks to Buy

Short Sellers Hike Bets in Major Pharma Stocks

Disney, Pfizer Keep the Dow Flat Wednesday

Disney, DowDuPont Set Pace for the Dow Monday

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Pfizer : PFE

All Pfizer Articles

Pfizer Announces Big Changes at the Top

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Major Biopharma Catalysts on September’s FDA Calendar

Pfizer Slips Despite Strong Late-Stage Results

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

How the FDA Is Fighting the Nationwide EpiPen Shortage

Apple, Caterpillar Dominate the Dow Friday

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Current Bull Market Not Over Until It’s Over: 5 US Stocks to Buy

Short Sellers Hike Bets in Major Pharma Stocks

Disney, Pfizer Keep the Dow Flat Wednesday

Disney, DowDuPont Set Pace for the Dow Monday

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up